Literature DB >> 12732114

[Acinetobacter baumannii bacteremia: clinical and prognostic features].

Jesús Rodríguez-Baño1, Alvaro Pascual, Juan Gálvez, Miguel Angel Muniain, M José Ríos, Luis Martínez-Martínez, Ramón Pérez-Cano, Evelio J Perea.   

Abstract

OBJECTIVE: The incidence, clinical features, and prognosis of bacteremia due to Acinetobacter baumannii were investigated.
METHODS: Prospective study of all episodes of A. baumanii bacteremia detected during the period of January 1995 to December 1998. A. baumannii was identified using recent standard methods.
RESULTS: A total of 133 episodes of bacteremia due to A. baumannii were studied, all of them nosocomial-acquired. The incidence-density diminished from 2.02 episodes per 10,000 patient-days to 0.40 episodes per 10,000 patient-days after the implementation of a control program. Most of the patients (70%) were, or had been, in the ICU when bacteremia occurred. Some 80% of patients had a chronic illness and 62% had a Hilf's severity score > 4. Among the strains identified, 74% were multidrug-resistant and 28% were imipenem-resistant. Attributable mortality was 25.6%. Multivariate analysis showed that inappropriate antibiotic treatment, septic shock, and high Hilf's severity score were associated with poorer prognosis.
CONCLUSION: A. baumannii bacteremia mainly affects severely ill patients who have undergone several invasive procedures, and who may have relevant associated morbidity and mortality. Among other variables, inappropriate antibiotic treatment was a risk factor for increased mortalilty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732114     DOI: 10.1016/s0213-005x(03)72930-9

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  11 in total

1.  Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.

Authors:  Pilar Retamar; María M Portillo; María Dolores López-Prieto; Fernando Rodríguez-López; Marina de Cueto; María V García; María J Gómez; Alfonso Del Arco; Angel Muñoz; Antonio Sánchez-Porto; Manuel Torres-Tortosa; Andrés Martín-Aspas; Ascensión Arroyo; Carolina García-Figueras; Federico Acosta; Juan E Corzo; Laura León-Ruiz; Trinidad Escobar-Lara; Jesús Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 2.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

3.  In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.

Authors:  Marc H Scheetz; Chao Qi; John R Warren; Michael J Postelnick; Teresa Zembower; Arlene Obias; Gary A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

4.  Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.

Authors:  Dana R Bowers; Henry Cao; Jian Zhou; Kimberly R Ledesma; Dongxu Sun; Olga Lomovskaya; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

Review 7.  Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

8.  Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.

Authors:  Hua Zhou; Yake Yao; Bingquan Zhu; Danhong Ren; Qing Yang; Yiqi Fu; Yunsong Yu; Jianying Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 9.  Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-07-14       Impact factor: 6.244

10.  A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.

Authors:  Sofia Maraki; Elpis Mantadakis; Viktoria Eirini Mavromanolaki; Diamantis P Kofteridis; George Samonis
Journal:  Infect Chemother       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.